The 8th CCP Summit is the longest-standing industry-focused and cross-modality meeting, delving into the scientific and strategic challenges that have the potential to significantly expedite the adoption and scale-up of continuous processing.

Carefully curated in collaboration with industry leaders, the summit offers a content-rich experience with cutting-edge presentations from leading pharma and biotech. Over the course of three days of unmissable content across small molecules, biologics and new addition of ATMPs, this forum will harmoniously pair technical case studies with the business-case-realities to leave you with the definitive answer of why NOT continuous processing. As adaption and acceptance of this innovative technology gathers speed, accompanied by enhanced  regulatory guidance from the FDA and ICH Q13, the 8th CCP Summit will unite 140+ senior stakeholders. They will share insights into  their continuous manufacturing journeys, providing inspiration to overcome pressing challenges to accelerate quality drug products speed-to-market through end-to-end continuous manufacturing implementation.